These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 66285)

  • 1. Genetics of cell-mediated lympholysis in man.
    Geha RS; Malakian A; Geha O; Yunis E
    J Immunol; 1977 Apr; 118(4):1286-91. PubMed ID: 66285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics of cell-mediated lympholysis.
    Long MA; Handwerger BS; Amos DB; Yunis EJ
    J Immunol; 1976 Dec; 117(6):2092-9. PubMed ID: 62806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of human CML target. HLA-B locus (B12) antigen variants defined by CTL generated between B locus-identical (B12) responder-stimulator pairs.
    Kato S; Iványi P; Lacko E; Breur B; Du Bois R; Eijsvoogel VP
    J Immunol; 1982 Feb; 128(2):949-55. PubMed ID: 6976390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A suppressor T cell of the mixed lymphocyte reaction specific for the HLA-D region in man.
    Engleman EG; McDevitt HO
    J Clin Invest; 1978 Mar; 61(3):828-38. PubMed ID: 147885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular requirements for the generation of primary cell-mediated lympholysis responses to Qa-1 antigens.
    Huston DP; Jenkins RN; Gresens SE; Smith R; Rich RR
    J Immunol; 1985 Apr; 134(4):2198-204. PubMed ID: 3156180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The specificty and the activation mechanism of cell-mediated lympholysis (CML) in man.
    Eijsvoogel VP; du Bois MJ; Meinesz A; Bierhorst-Eijlander A; Zeylemaker WP; Schellekens PT
    Transplant Proc; 1973 Dec; 5(4):1675-8. PubMed ID: 4130075
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytostatic effector cells generated in vivo against M locus determinants.
    Matossian-Rogers A; Festenstein H
    Clin Exp Immunol; 1977 Feb; 27(2):335-9. PubMed ID: 66115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro cellular response of human lymphocytes to trinitrophenylated autologous cells: HLA-D restriction of proliferation but apparent absence of HLA restriction of cytolysis.
    Charmot D; Mawas C
    Eur J Immunol; 1979 Sep; 9(9):723-30. PubMed ID: 159827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-restricted cell-mediated cytotoxicity directed against male specific (H-Y) antigen after acute rejection of an HLA-identical sibling kidney.
    Pfeffer PF; Sødal G; Thorsby E
    Scand J Urol Nephrol Suppl; 1981; 64():72-8. PubMed ID: 6216585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexity of the HLA-D region studied by primed-lymphocyte test.
    Segall M; Reinsmoen NL; Noreen HJ; Bach FH
    J Exp Med; 1980 Aug; 152(2 Pt 2):156s-163s. PubMed ID: 6157765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated lympholysis in man: CML specificities and their possible relevance.
    Kristensen T
    Transplant Proc; 1978 Jun; 10(2):319-25. PubMed ID: 79254
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional cell mediated lympholysis: II. Genetics.
    Goeken NE; Thompson JS
    Tissue Antigens; 1981; 17(4):411-20. PubMed ID: 6949337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA restriction of non-HLA--A, --B, --C and --D cell mediated lympholysis (CML).
    Goulmy E; Termijtelen A; Bradley BA; van Rood JJ
    Tissue Antigens; 1976 Nov; 8(5):317-26. PubMed ID: 65023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An estimate of the recombination frequency between the B locus and the D locus within the major histocompatibility complex.
    Mickelson EM; Petersons JS; Flournoy N; Clift RA; Thomas ED
    Tissue Antigens; 1976 Oct; 8(4):247-52. PubMed ID: 136066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA factors and immune function.
    Svejgaard A
    Acta Endocrinol Suppl (Copenh); 1976; 205():77-84. PubMed ID: 63212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA regulates postrenal transplant CML nonreactivity.
    Goulmy E; Blokland E; Persijn G; Paul LC; Wilmink J; van Rood JJ
    J Immunol; 1985 Nov; 135(5):3082-6. PubMed ID: 3900203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated lympholysis: examination of HLA genetic fine structure and complementation using cytotoxic lymphocytes.
    Schendel DJ; Wank R; Dupont B
    Eur J Immunol; 1978 Sep; 8(9):634-40. PubMed ID: 152205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexity of stimulation in MLC and the influence of matching for HLA-A and -B.
    Termijtelen A; van Rood JJ
    Scand J Immunol; 1981 Nov; 14(5):459-66. PubMed ID: 6461063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation.
    Harmon WE; Parkman R; Lavin PT; Grupe WE; Ingelfinger JR; Yunis EJ; Levey RH
    J Immunol; 1982 Oct; 129(4):1573-7. PubMed ID: 6213715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.